BIG POTATOES

In 2005, China’s engineers and scientists completed a new railway. Splicing through mountains five kilometres high and underground rock formations where the temperatures run at -30°C, the new line stretches from Golmud in the province of Qinghai to Lhasa, the capital of Tibet. No fewer than 1,142 km long, it was finished three years ahead of schedule. [1]

The railway is a triumph not just of engineering, but also of conscious risk-taking. Barriers thought very hard to overcome were proved surmountable.

That sequence of events, in which risks are confronted, is a relative rarity these days.

James Woudhuysen argues that the biopharmaceuticals giant Pfizer’s decision earlier this year to close the company’s labs in Sandwich, south-east England, exposed the Lib-Con coalition government’s lack of any strategy for growth. Analysing the trends in pharmaceutical research and societal attitudes to it over the last fifty years he argues that:

The agenda in society today is much more about nudging you to change your diet or your exercise than it is about having hopes that they will come up with wonder drugs. That agenda supplies the real, overarching and dominant context behind the drive, by big pharmaceutical companies such as Pfizer, to get out of research.

Big Pharma, small ambition, James Woudhuysen, spiked, 21 February 2011